These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 7681802)

  • 1. Synthesis and suppression of IgE antibodies.
    Greenberger PA
    Allergy Proc; 1993; 14(1):61-2. PubMed ID: 7681802
    [No Abstract]   [Full Text] [Related]  

  • 2. Neuropeptide-mediated regulation of hapten-specific IgE responses in mice. II. Mechanisms of substance P-mediated isotype-specific suppression of BPO-specific IgE antibody-forming cell responses induced in vitro.
    Carucci JA; Herrick CA; Durkin HG
    J Neuroimmunol; 1994 Jan; 49(1-2):89-95. PubMed ID: 7507499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclosporine A acts as a potent co-stimulator in up-regulation of IgE antibody synthesis and expression of Fc receptor for IgE--a unifying hypothesis of the cellular mechanisms of cyclosporine A.
    Chen SS
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):92-102. PubMed ID: 2966485
    [No Abstract]   [Full Text] [Related]  

  • 4. Cyclosporin A induced suppression of ongoing IgE antibody formation in the mouse.
    Miyamoto T; Terada E; Okudaira H
    Int Arch Allergy Appl Immunol; 1985; 77(1-2):235-7. PubMed ID: 3159684
    [No Abstract]   [Full Text] [Related]  

  • 5. The IgE and IgG subclass antibody response in patients allergic to yellow jacket venom undergoing different regimens of venom immunotherapy.
    Djurup R; Malling HJ; Søndergaard I; Weeke B
    J Allergy Clin Immunol; 1985 Jul; 76(1):46-55. PubMed ID: 4008813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospects for the clinical control of IgE synthesis.
    Katz DH
    Prog Clin Immunol; 1980; 4():127-50. PubMed ID: 6992217
    [No Abstract]   [Full Text] [Related]  

  • 7. Neuropeptide-mediated regulation of hapten-specific IgE responses in mice. I. Substance P-mediated isotype-specific suppression of BPO-specific IgE antibody-forming cell responses induced in vivo and in vitro.
    Carucci JA; Auci DL; Herrick CA; Durkin HG
    J Leukoc Biol; 1995 Jan; 57(1):110-5. PubMed ID: 7530276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors influencing human IgE synthesis in vitro and in vivo.
    de Weck AL; Stadler BM; Knutti-Müller J; Ruff P; Hofstetter H; Lüdin C; Heusser C
    Int Arch Allergy Appl Immunol; 1985; 77(1-2):38-44. PubMed ID: 3874169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Regulation of Ige synthesis and cytokines in selected allergic diseases].
    Michałkiewicz J; Nowacka K; Stachowski J; Gregorek H; Madaliński K
    Pediatr Pol; 1996 Jan; 71(1):47-56. PubMed ID: 8966067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A computational approach to the description of individual immune responses. IgE and IgG-subclass allergen-specific antibodies formed during immunotherapy.
    Søndergaard I; Poulsen LK; Osterballe O; Weeke B
    Allergy; 1991 Jan; 46(1):10-9. PubMed ID: 2018204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin 13 induces interleukin 4-independent IgG4 and IgE synthesis and CD23 expression by human B cells.
    Punnonen J; Aversa G; Cocks BG; McKenzie AN; Menon S; Zurawski G; de Waal Malefyt R; de Vries JE
    Proc Natl Acad Sci U S A; 1993 Apr; 90(8):3730-4. PubMed ID: 8097323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of soluble antigen on IgE responses in the mouse.
    Sauerbronn Maia LC; Vaz NM; Vaz EM
    Int Arch Allergy Appl Immunol; 1974; 46(3):339-44. PubMed ID: 4418534
    [No Abstract]   [Full Text] [Related]  

  • 13. Regulation of immunoglobulin E antibody synthesis in man by antiidiotypic antibodies.
    Geha RS; Comunale M
    J Clin Invest; 1983 Jan; 71(1):46-54. PubMed ID: 6600236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Immunopharmacological study of buckwheat hypersensitivity III. Effect of dialysate-conjugated T cell mitogen on IgE formation (author's transl)].
    Yanagihara Y; Koda A
    Nihon Yakurigaku Zasshi; 1979 Oct; 75(7):755-63. PubMed ID: 161546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IgE regulation during immunotherapy of allergic diseases.
    Perelmutter L
    Ann Allergy; 1986 Aug; 57(2):78-85. PubMed ID: 2943197
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of immunotherapy on immunoglobulin E and immunoglobulin G antibodies to ragweed antigens: a six-year prospective study.
    Gleich GJ; Zimmermann EM; Henderson LL; Yunginger JW
    J Allergy Clin Immunol; 1982 Oct; 70(4):261-71. PubMed ID: 6811645
    [No Abstract]   [Full Text] [Related]  

  • 17. A mechanism for the suppression of ongoing IgE synthesis.
    Sherr EH; Saxon A
    Int Arch Allergy Appl Immunol; 1987; 82(3-4):414-6. PubMed ID: 2952603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection and characterization of IgE-producing cells in patients with clonorchiasis.
    Yanagihara Y; Kiniwa M; Kajiwara K; Joh K; Kobayashi A; Watanabe N
    Int Arch Allergy Appl Immunol; 1989; 89(2-3):197-201. PubMed ID: 2668200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence of a common regulation of IgE and IgG-subclass antibodies in humans during immunotherapy.
    Søndergaard I; Poulsen LK; Osterballe O; Weeke B
    Allergy; 1992 Oct; 47(5):467-70. PubMed ID: 1485649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose response of IgE and IgG antibodies during ragweed immunotherapy.
    Creticos PS; Van Metre TE; Mardiney MR; Rosenberg GL; Norman PS; Adkinson NF
    J Allergy Clin Immunol; 1984 Jan; 73(1 Pt 1):94-104. PubMed ID: 6607272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.